Interplay Between Zero CAC, Quantitative Plaque Analysis, and Adverse Events in a Diverse Patient Cohort.
cardiovascular
chest pain
coronary artery calcium score
plaque analysis
power of zero
Journal
Circulation. Cardiovascular imaging
ISSN: 1942-0080
Titre abrégé: Circ Cardiovasc Imaging
Pays: United States
ID NLM: 101479935
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
pmc-release:
10
08
2024
medline:
17
8
2023
pubmed:
15
8
2023
entrez:
15
8
2023
Statut:
ppublish
Résumé
Coronary artery calcium scoring (CAC) has garnered attention in the diagnostic approach to chest pain patients. However, little is known about the interplay between zero CAC, sex, race, ethnicity, and quantitative coronary plaque analysis. We conducted a retrospective analysis from our computed tomography registry of patients with stable angina without prior myocardial infarction or revascularization undergoing coronary computed tomography angiography at Montefiore Healthcare System. Follow-up end points collected included invasive angiography, type-1 myocardial infarction, coronary revascularization, cardiovascular and all-cause death. A total of 2249 patients were included (66% female). The median follow-up was 5.5 years. The median age of those without CAC was 52 years (interquartile range, 44-59) and 60 years (interquartile range, 53-68) in those with CAC. Most patients were Hispanic (58%), and the rest were non-Hispanic Black (28%), non-Hispanic White (10%), and non-Hispanic Asian (5%). The majority had CAC=0 (55%). The negative predictive value of CAC=0 was 92.8%, 99.9%, and 99.9% for any plaque, obstructive coronary artery stenosis, and the composite outcome of all-cause death, myocardial infarction, or coronary revascularization, respectively. Among patients without CAC (n=1237), 89 patients (7%) had evidence of plaque on their coronary computed tomography angiography with a median low-attenuation noncalcified plaque burden of 4% (2-7). There were no significant differences in the negative predictive value for CAC=0 by sex, race, or ethnicity. Patients with ≥2 risk factors had higher odds of having plaque with zero CAC. In summary, no sex, race, or ethnicity differences were demonstrated in the negative predictive value of a zero CAC; however, patients with ≥2 risk factors had a higher prevalence of plaque. A small percentage (7%) of symptomatic patients undergoing coronary computed tomography angiography with zero CAC had noncalcified coronary plaque, with the implication that caution is needed for downscaling of preventive treatment in patients with zero CAC, chest pain, and multiple risk factors.
Sections du résumé
BACKGROUND
Coronary artery calcium scoring (CAC) has garnered attention in the diagnostic approach to chest pain patients. However, little is known about the interplay between zero CAC, sex, race, ethnicity, and quantitative coronary plaque analysis.
METHODS
We conducted a retrospective analysis from our computed tomography registry of patients with stable angina without prior myocardial infarction or revascularization undergoing coronary computed tomography angiography at Montefiore Healthcare System. Follow-up end points collected included invasive angiography, type-1 myocardial infarction, coronary revascularization, cardiovascular and all-cause death.
RESULTS
A total of 2249 patients were included (66% female). The median follow-up was 5.5 years. The median age of those without CAC was 52 years (interquartile range, 44-59) and 60 years (interquartile range, 53-68) in those with CAC. Most patients were Hispanic (58%), and the rest were non-Hispanic Black (28%), non-Hispanic White (10%), and non-Hispanic Asian (5%). The majority had CAC=0 (55%). The negative predictive value of CAC=0 was 92.8%, 99.9%, and 99.9% for any plaque, obstructive coronary artery stenosis, and the composite outcome of all-cause death, myocardial infarction, or coronary revascularization, respectively. Among patients without CAC (n=1237), 89 patients (7%) had evidence of plaque on their coronary computed tomography angiography with a median low-attenuation noncalcified plaque burden of 4% (2-7). There were no significant differences in the negative predictive value for CAC=0 by sex, race, or ethnicity. Patients with ≥2 risk factors had higher odds of having plaque with zero CAC.
CONCLUSIONS
In summary, no sex, race, or ethnicity differences were demonstrated in the negative predictive value of a zero CAC; however, patients with ≥2 risk factors had a higher prevalence of plaque. A small percentage (7%) of symptomatic patients undergoing coronary computed tomography angiography with zero CAC had noncalcified coronary plaque, with the implication that caution is needed for downscaling of preventive treatment in patients with zero CAC, chest pain, and multiple risk factors.
Identifiants
pubmed: 37582155
doi: 10.1161/CIRCIMAGING.123.015236
pmc: PMC10430772
mid: NIHMS1919177
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e015236Subventions
Organisme : NHLBI NIH HHS
ID : P50 HL120163
Pays : United States
Organisme : NHLBI NIH HHS
ID : K02 HL004199
Pays : United States
Organisme : CLC NIH HHS
ID : 75N90019D00011
Pays : United States
Organisme : NHLBI NIH HHS
ID : 75N92021D00011
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL148787
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL151266
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL146204
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL144707
Pays : United States
Références
JACC Cardiovasc Imaging. 2016 Sep;9(9):1099-1113
pubmed: 27609151
N Engl J Med. 2018 Sep 06;379(10):924-933
pubmed: 30145934
J Am Coll Cardiol. 2021 Nov 30;78(22):2218-2261
pubmed: 34756652
Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73
pubmed: 24222018
JACC Cardiovasc Imaging. 2009 Jun;2(6):675-88
pubmed: 19520336
J Am Coll Cardiol. 2018 Jul 24;72(4):434-447
pubmed: 30025580
JACC Cardiovasc Imaging. 2009 Jun;2(6):692-700
pubmed: 19520338
Circulation. 2014 Aug 12;130(7):593-625
pubmed: 25098323
Circulation. 2021 Sep 21;144(12):916-929
pubmed: 34543072
Am J Med. 2011 Sep;124(9):868-74
pubmed: 21745651
J Am Coll Cardiol. 2019 Jan 29;73(3):291-301
pubmed: 30678759
Eur Heart J. 2016 Apr 14;37(15):1232-43
pubmed: 26746631
J Cardiovasc Comput Tomogr. 2017 Jan - Feb;11(1):74-84
pubmed: 27916431
Circulation. 2017 Nov 21;136(21):1993-2005
pubmed: 28847895
JACC Cardiovasc Imaging. 2022 Oct;15(10):1745-1757
pubmed: 36202453
J Am Coll Cardiol. 2011 Dec 6;58(24):2533-40
pubmed: 22079127
Clin Chem. 1972 Jun;18(6):499-502
pubmed: 4337382
JACC Cardiovasc Imaging. 2022 Sep;15(9):1604-1618
pubmed: 36075621
J Am Coll Cardiol. 1990 Mar 15;15(4):827-32
pubmed: 2407762
Circulation. 2005 Mar 15;111(10):1313-20
pubmed: 15769774
JAMA Cardiol. 2022 Mar 01;7(3):259-267
pubmed: 34935857
J Am Heart Assoc. 2018 Oct 16;7(20):e010471
pubmed: 30371271
JACC Cardiovasc Imaging. 2021 May;14(5):990-1002
pubmed: 33129734